Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Virology|September 25, 2009
The myxoma virus m-t5 ankyrin repeat host range protein is a novel adaptor that coordinately links the cellular signaling pathways mediated by Akt and Skp1 in virus-infected cellsSteven J Werden, Jerry Lanchbury, Donna Shattuck, et al.
Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society|July 12, 2003
A virtual reality system for neurobehavioral and functional MRI studiesStephen Baumann, Chris Neff, Scott Fetzick, et al.
Plos One|August 17, 2010
The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestisMatthew D Dyer, Chris Neff, Max Dufford, et al.
Journal of Proteome Research|July 30, 2009
Analysis of vaccinia virus-host protein-protein interactions: validations of yeast two-hybrid screeningsLeiliang Zhang, Nancy Y Villa, Masmudur M Rahman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxvirusesMohamed R Mohamed, Masmudur M Rahman, Jerry S Lanchbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
Breast Cancer Research : BCR|December 6, 2014
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesKirsten M Timms, Victor Abkevich, Elisha Hughes, et al.
Breast Cancer Research and Treatment|December 25, 2017
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancerMelinda L Telli, Jessica Hellyer, William Audeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L Telli, Charles Chu, Sunil S Badve, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Pageof 2